1471-4914
Monthly
No
TRENDS MOL MED
2001
72
ENGLAND
http://www.cell.com/trends/molecular-medicine/home
較慢,6-12周審稿時(shí)間
多是約稿平均錄用比例
11.028影響因子
生化與分子生物學(xué)小學(xué)科
月期刊平臺(tái)服務(wù)過(guò)的文章錄用時(shí)間為1-3個(gè)月,依據(jù)20年經(jīng)驗(yàn),經(jīng)月期刊專(zhuān)家預(yù)審?fù)ㄟ^(guò)后的文章,投稿通過(guò)率100%以上!
由愛(ài)思唯爾科學(xué)出版。ISSN: 1471-4914。分子醫(yī)學(xué)趨勢(shì)的目標(biāo)是促進(jìn)具有不同背景和技能的受過(guò)高度訓(xùn)練的專(zhuān)業(yè)人員之間的交流,他們的共同目標(biāo)是了解和解釋疾病的分子基礎(chǔ),以便新的臨床實(shí)踐。分子醫(yī)學(xué)趨勢(shì)是學(xué)生和專(zhuān)業(yè)人士的資源,他們有超越傳統(tǒng)臨床或科學(xué)分類(lèi)的信息需求。分子醫(yī)學(xué)的發(fā)展趨勢(shì)包括對(duì)疾病遺傳基礎(chǔ)的綜述文章,但“分子”并不僅僅指DNA。遺傳過(guò)程的診斷作用是明確的,但對(duì)健康和疾病的主要好處也由其他分子提供:酶、抗生素、激素、金屬、碳水化合物、脂類(lèi)、維生素、合成有機(jī)和無(wú)機(jī)聚合物。這些好處是討論和評(píng)估在分子醫(yī)學(xué)的趨勢(shì)。此外,“醫(yī)學(xué)”涉及一個(gè)重要的社會(huì)因素;分子干預(yù)引發(fā)了有爭(zhēng)議的倫理、法律和財(cái)務(wù)問(wèn)題。所有這些問(wèn)題都在《分子醫(yī)學(xué)趨勢(shì)》雜志上以25年出版《趨勢(shì)》雜志的經(jīng)驗(yàn)為基礎(chǔ)進(jìn)行了探討。
http://www.editorialmanager.com/trmome/default.aspx?__hstc=2
Published by Elsevier Science. ISSN: 1471-4914.Trends in Molecular Medicine's objective is to facilitate communication between groups of highly trained professionals with distinct backgrounds and skills, whose common goals are to understand and explain the molecular basis of disease with a view to new clinical practice. Trends in Molecular Medicine is a resource for students and professionals alike, who have information needs that transcend the traditional clinical or scientific categorisation. Trends in Molecular Medicine includes review articles on the genetic basis of disease, but 'molecular' does not only mean DNA. The diagnostic role of genetic processes is clear, but major benefits in health and disease are also provided by other molecules: enzymes, antibiotics, hormones, metals, carbohydrates, lipids, vitamins, synthetic organic and inorganic polymers. Such benefits are discussed and evaluated by Trends in Molecular Medicine. Furthermore 'Medicine' involves a vital societal element; molecular intervention raises controversial ethical, legal and financial issues. All these issues are addressed in Trends in Molecular Medicine in a style that builds on 25 years' experience of publishing the Trends Journals.
快速預(yù)審、投刊前指導(dǎo)、專(zhuān)業(yè)學(xué)術(shù)評(píng)審,對(duì)文章進(jìn)行評(píng)價(jià);
立即咨詢(xún)校對(duì)編輯、深度潤(rùn)色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢(xún)適用于語(yǔ)句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢(xún)數(shù)據(jù)庫(kù)包括:期刊、文章、書(shū)籍、會(huì)議、預(yù)印書(shū)、百科全書(shū)和摘要等;
立即咨詢(xún)讓作者在期刊選擇時(shí)避免走彎路,縮短稿件被接收的周期;
立即咨詢(xún)根據(jù)目標(biāo)期刊格式要求對(duì)作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢(xún)幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢(xún)按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢(xún)大類(lèi)學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類(lèi)學(xué)科 | 小類(lèi)學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 醫(yī)學(xué) | 生化與分子生物學(xué) | 6.887 | N/A | 0304-419X |
BIOORGANIC & MEDICINAL CHEMISTRY | 醫(yī)學(xué) | 生化與分子生物學(xué) | 2.802 | 3區(qū) | 0968-0896 |
Chemical Biology & Drug Design | 醫(yī)學(xué) | 生化與分子生物學(xué) | 2.256 | 4區(qū) | 1747-0277 |
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY | 醫(yī)學(xué) | 生化與分子生物學(xué) | 2.697 | N/A | 1532-0456 |
CURRENT DRUG METABOLISM | 醫(yī)學(xué) | 生化與分子生物學(xué) | 2.277 | 3區(qū) | 1389-2002 |
INFECT MED | 醫(yī)學(xué) | 生化與分子生物學(xué) | N/A | 3區(qū) | 0929-8673 |
MED ORAL PATOL ORAL | 醫(yī)學(xué) | 生化與分子生物學(xué) | N/A | N/A | 0957-9672 |
CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 醫(yī)學(xué) | 生化與分子生物學(xué) | 1.516 | N/A | 1389-2010 |
CYTOKINE | 醫(yī)學(xué) | 生化與分子生物學(xué) | 3.078 | 3區(qū) | 1043-4666 |
EXPERIMENTAL AND MOLECULAR MEDICINE | 醫(yī)學(xué) | 生化與分子生物學(xué) | 4.743 | 2區(qū) | 1226-3613 |
發(fā)現(xiàn)心儀選題請(qǐng)?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊